Legal Calls sells exclusive Cartiva leads and signed retainers to law firms. Claimants allege the recalled Cartiva synthetic cartilage big-toe implant sank, loosened or broke apart, causing pain and requiring removal or fusion surgery. Leads come from our own Meta, TikTok and Google ads, are screened in-house, and are delivered by CRM, API, email or warm transfer.
| Case type | Medical device product liability (big-toe implant) |
| Litigation | MDL No. 3172, E.D. Ark., Chief Judge Kristine G. Baker (created Feb 5, 2026) |
| Alleged injuries | Implant subsidence, loosening or fragmentation; revision, removal or fusion |
| Lead sources | Meta, TikTok & Google ads — no affiliates |
| What you get | Exclusive leads or signed retainers |
| Delivery | CRM, API, email or warm transfer |
| Intake | In-house team, under 1-minute speed-to-lead |
| Proof | TrustedForm certificate, call recordings, ad account access |
| Volume | On request |
| Last reviewed | November 2026 |
On February 5, 2026 the JPML created MDL No. 3172, In re: Cartiva Synthetic Cartilage Implant Products Liability Litigation, in the Eastern District of Arkansas before Chief Judge Kristine G. Baker. Cartiva, Inc. is the named defendant; the Panel noted Wright Medical Group N.V. as its corporate successor.
Cartiva, Inc., now part of Stryker, initiated a recall of the implant on October 31, 2024, covering all lots distributed from July 2016 to October 2024. The FDA classified it Class II, citing higher-than-expected revision, removal, subsidence, displacement, pain, nerve damage and fragmentation.
The MDL is at an early pretrial stage as of November 2026. Leadership was appointed in late August 2026, a status hearing was held on October 8, 2026, and another is set for December 10, 2026. The JPML reported 22 pending cases as of November 2, 2026; no bellwether schedule or settlement has been announced.
Sources: JPML Transfer Order, MDL No. 3172 · MDL No. 3172 court page (E.D. Ark.) · FDA Recall Database: Cartiva Synthetic Cartilage Implant (Z-0598-2025) · Cartiva Implant Lawsuits (King Law). Status as of November 2026.
Criteria shown is generalized based on current standards in this mass tort. Tailored criteria sets are available to meet client specifications.
Exclusive Cartiva leads: pre-screened claimants delivered in real time to your CRM, by API, by email or as a warm transfer, for your own team to sign.
Signed Cartiva retainers: our in-house intake team qualifies the claimant and collects the signed retainer and HIPAA authorization before the case is delivered.
Pricing: a percentage of ad spend, or a fixed price per signed retainer. Volume is available on request.
Yes. The JPML created MDL No. 3172 on February 5, 2026 in the Eastern District of Arkansas, assigned to Chief Judge Kristine G. Baker.
Yes. Cartiva, Inc. initiated a recall on October 31, 2024 for all lots distributed from July 2016 through October 2024, and the FDA classified it Class II.
Implant subsidence, loosening, displacement or fragmentation causing pain and loss of motion, especially where revision, removal or fusion of the big-toe joint followed.
Yes. Each lead is sold to one firm only and comes from our own ads, not affiliates, with a TrustedForm certificate and call recording.
Yes. Firms can buy exclusive leads or signed retainers, priced as a percentage of ad spend or a fixed price per signed retainer.
Early pretrial. Leadership was appointed in late August 2026, a status hearing is set for December 10, 2026, and no trials or settlement were scheduled as of November 2026.
Spinal Cord Stimulator Leads · Paragard Leads · Hernia Mesh Leads · Mass Tort Intake · All mass tort case leads
Prices are always changing and tend to rise over time. We work with you to get the lowest client acquisition cost in the industry by tailoring our service to your needs.
Book a time with our VP, and he’ll walk you through pricing and strategy step by step.